Developing brain as an endocrine organ: secretion of dopamine

Mol Cell Endocrinol. 2012 Jan 2;348(1):78-86. doi: 10.1016/j.mce.2011.07.038. Epub 2011 Jul 30.

Abstract

This study was aimed to test our hypothesis that the developing brain operates as an endocrine organ before the establishment of the blood-brain barrier (BBB), in rats up to the first postnatal week. Dopamine (DA) was selected as a marker of the brain endocrine activity. The hypothesis was supported by the observations in rats of: (i) the physiological concentration of DA in peripheral blood of fetuses and neonates, before the BBB establishment, and its drop by prepubertal period, after the BBB development; (ii) a drop of the DA concentration in the brain for 54% and in blood for 74% on the 3rd postnatal day after the intraventricular administration of 50 μg of α-methyl-p-tyrosine, an inhibitor of DA synthesis, with no changes in the DA metabolism in peripheral DA-producing organs. Thus, the developing brain is a principal source of circulating DA which is capable of providing an endocrine regulation of peripheral organs and the brain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3,4-Dihydroxyphenylacetic Acid / blood
  • 3,4-Dihydroxyphenylacetic Acid / metabolism
  • Animals
  • Blood-Brain Barrier / embryology
  • Blood-Brain Barrier / growth & development
  • Brain / embryology
  • Brain / growth & development*
  • Brain / metabolism
  • Dopamine / blood
  • Dopamine / metabolism*
  • Female
  • Hypothalamus / metabolism
  • Male
  • Mesencephalon / metabolism
  • Neurosecretory Systems / embryology
  • Neurosecretory Systems / growth & development*
  • Pregnancy
  • Rats
  • Rats, Wistar
  • Rhombencephalon / metabolism
  • Tyrosine 3-Monooxygenase / antagonists & inhibitors
  • alpha-Methyltyrosine / pharmacology

Substances

  • 3,4-Dihydroxyphenylacetic Acid
  • alpha-Methyltyrosine
  • Tyrosine 3-Monooxygenase
  • Dopamine